Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Dexmedetomidine vs magnesium as intraperitoneal add-ons to bupivacaine for laparoscopic gallbladder removal

Official title: Intraperitoneal Instillation of Dexmedetomidine Versus Magnesium Sulphate as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy

Run by Alexandria University · NCT07693621 · Data updated 2026-11-12

This study tests whether adding dexmedetomidine or magnesium sulfate to bupivacaine injected inside the abdomen provides better pain relief after laparoscopic cholecystectomy for adults without serious health issues.

More Dexmedetomidine trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment80 (estimated)
SponsorAlexandria University
Academic / other
Locations1 site (Alexandria)
StatusRecruiting
StartedMay 3, 2026
Main results expectedNovember 3, 2026
Study endsJanuary 1, 2027
Registry record updatedJuly 9, 2026
Trial IDNCT07693621 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-60 with ASA I-II scheduled for elective laparoscopic cholecystectomy who can receive intraperitoneal injections and do not have contraindications to dexmedetomidine or magnesium.

Probably not a fit

Patients with arrhythmias, significant organ impairment, or other exclusions may not experience additional analgesic benefits from these adjuvants.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two intraperitoneal adjuvants mixed with bupivacaine during laparoscopic cholecystectomy to see which offers better postoperative analgesia. The design uses two arms: bupivacaine 100 mg with dexmedetomidine 1 mcg/kg and bupivacaine 100 mg with magnesium sulfate 50 mg/kg. Eligible participants are adults aged 18-60 with ASA I-II undergoing elective laparoscopic cholecystectomy under general anesthesia. Outcomes focus on analgesic effectiveness and safety, contributing to multimodal pain strategies in this common procedure.

Why it matters

Potential benefit: If successful, the preferred adjuvant could provide improved pain control and potentially reduce opioid requirements after surgery.

How similar studies have gone: Previous studies have shown potential analgesic benefits for both adjuvants with local anesthetics, but direct intraperitoneal head-to-head comparisons in this setting are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18-60 years
* ASA physical status I-II
* scheduled for elective laparoscopic cholecystectomy under general anesthesia.

Exclusion Criteria:

* Known hypersensitivity to study drugs
* history of cardiac arrhythmias or conduction abnormalities
* severe hepatic/renal impairment
* chronic opioid or analgesic use
* pregnancy
* conversion to open surgery
* drain insertion.

Where it's running

  • Alexandria University
    Alexandria, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.